SPEARHEAD CAPITAL ADVISORS, LLC – Kiniksa Pharmaceuticals, Ltd. Transaction History
SPEARHEAD CAPITAL ADVISORS, LLC portfolio value:
$2.60M
portfolio value
SPEARHEAD CAPITAL ADVISORS, LLC quarter portfolio value change:
+32.51%
quarter
Kiniksa Pharmaceuticals, Ltd. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.80% | -32.44K shares | 324K | $12.84 | 202.58K |
| Q2 2022 | share | 0.00% | 0 shares | -59K | $9.69 | 235.02K | |
| Q1 2022 | share | 0.00% | 0 shares | -430K | $9.94 | 235.02K | |
| Q4 2021 | share | 0.00% | 0 shares | 89K | $11.97 | 235.02K | |
| Q3 2021 | share | 0.00% | 0 shares | -597K | $11.39 | 235.02K | |
| Q2 2021 | share | Decrease | -37.63% | -141.82K shares | -3.70M | $13.93 | 235.02K |
| Q1 2021 | share | Increase | +39.51% | 106.72K shares | 2.20M | $18.51 | 376.84K |
| Q4 2020 | share | 0.00% | 0 shares | 635K | $17.67 | 270.11K | |
| Q3 2020 | share | Decrease | -0.25% | -678 shares | -2.76M | $15.32 | 270.11K |
| Q2 2020 | share | 0.00% | 0 shares | 2.70M | $25.48 | 270.79K | |
| Q1 2020 | share | Increase | 0.00% | 270.79K shares | 4.19M | $15.48 | 270.79K |